Skip to main content

Table 3 Major findings of the RCTs included in the review

From: Efficacy and safety of traditional Chinese medicines for non-alcoholic fatty liver disease: a systematic literature review of randomized controlled trials

No.

Authors, year

Test group

Control group

Duration

Primary outcome

Secondary outcome

TCMs

Behavioral interventions

Pharmacological interventions

Behavioral interventions

TCM syndrome score

Adverse reactions

Radiological response

Liver function

Body weight

Blood sugar

Blood lipid

Others

1

Wu et al., 2020 [43]

Jianpi Qingzhi prescription

Diet and exercise

Polyene Phosphatidylcholine capsules

Diet and exercise

12 weeks

Yes

N/A

BU, CT

ALT, AST, GGT

N/A

FBG, FINs, HOMA-IR,

TG, TC

DAO, LPS, d-lactic acid, Claudin-1, Claudin-4

2

Lyv et al., 2020 [47]

Shenge formula

Diet and exercise

N/A

Diet and exercise

6 months

Yes

N/A

N/A

ALT, AST

N/A

N/A

TG, TC

N/A

3

Yang et al., 2019 [59]

Yanggan Jieyu granule

Diet and exercise

Polyene phosphatidylcholine capsules

Diet and exercise

24 weeks

Yes

N/A

CT

ALT, AST, GGT

N/A

N/A

TG, TC, LDL-C

N/A

4

Yang et al., 2019 [97]

Qinjiang Baoling decoction

Diet and exercise

N/A

Diet and exercise

3 months

Yes

N/A

BU, CT

ALT, GGT

BMI

HOMA-IR

TC, HDL-C

N/A

5

Li et al., 2018 [62]

Qutan Huoxue decoction

N/A

Silibinin capsules

N/A

24 weeks

Yes

Yes

CT

ALT, AST, GGT

N/A

N/A

TG, TC

N/A

6

Chen et al., 2017 [98]

Shuangqing granule

Diet and exercise

Xuezhikang capsules

Diet and exercise

12 weeks

Yes

N/A

BU

AST, ALT

N/A

N/A

TG, TC, HDL-C, LDL-C

N/A

7

Hu et al., 2017 [31]

Jianpishugan and Huoxuehuatan formula

Diet and exercise

Polyene Phosphatidylcholine capsules

Diet and exercise

3 months

Yes

Yes

BU

ALT, AST, GGT

BMI

N/A

TG, TC, HDL-C, LDL-C

N/A

8

Jiang et al., 2017 [41]

Dahuang Lidan capsule

Diet and exercise

Polyene Phosphatidylcholine capsules

Diet and exercise

12 weeks

Yes

Yes

BU

ALT, AST, GGT

N/A

N/A

TG, TC, HDL-C, LDL-C

N/A

9

Yang et al.,2017 [53]

Cigu Xiaozhi capsule

Diet and exercise

Polyene Phosphatidylcholine capsules

Diet and exercise

8 weeks

Yes

N/A

BU

ALT, AST, ALP, GGT

BMI

N/A

TG, TC, HDL-C, LDL-C

N/A

10

Jeong et al., 2017 [28]

Test group 1—HL tablet—high dose

N/A

Placebo

N/A

12 weeks

N/A

Yes

N/A

ALT, AST

BMI

HOMA-IR

TG, TC, HDL-C, LDL-C

MRS, free fatty acid

Test group 2—HL tablet—low dose

N/A

Placebo

N/A

12 weeks

N/A

11

Sun et al., 2017 [68]

Jianpi Qushi prescription

Diet and exercise

N/A

Diet and exercise

3 months

Yes

N/A

BU

ALT, AST

N/A

FPG, FINs

TG, TC

N/A

12

Niu 2016 [48]

Shugan Jianpi Huatan decoction

Diet and exercise

Atorvastatin calcium tablets

Diet and exercise

3 months

Yes

N/A

N/A

ALT, AST

N/A

FBG, FNIs, HOMA-IR

TG, TC

N/A

13

Zhang et al., 2016 [99]

Yiqi Qizhu decoction

Diet and exercise

Polyene phosphatidylcholine capsules

Diet and exercise

3 months

Yes

Yes

BU

ALT, AST, GGT

N/A

N/A

TG, TC

N/A

14

Zhang et al., 2016 [34]

Jiang Zhi granules

N/A

Ursodeoxycholic acid capsules

N/A

24 weeks

Yes

N/A

BU

N/A

N/A

N/A

N/A

N/A

15

Qi et al., 2016 [63]

Jiangpi Shugan Huoxue Huatan decoction

Diet and exercise

Silibinin capsules

N/A

3 months

Yes

N/A

BU

ALT, AST, GGT

N/A

N/A

TG, TC, HDL-C, LDL-C

N/A

16

Tan et al., 2016 [100]

Shugan Jianpi decoction

Diet and exercise

Pioglitazone

N/A

3 months

Yes

Yes

BU

ALT, AST

BMI, WHR

FBG, FNIs, HOMA-IR

TG, TC

N/A

17

Yu et al., 2016 [69]

Qinggan Jiangzhi decoction

Diet and exercise

Polyene phosphatidylcholine tablet and Dangfei Liganning capsule

Diet and exercise

24 weeks

Yes

N/A

BU

ALT, AST, GGT

BMI, BM

N/A

TG, TC

N/A

18

Yin et al., 2016 [35]

Danxia Zhifang decoction; simulated Zhiganxiao capsule

N/A

Qianggan capsule

N/A

3 months

Yes

N/A

BU, CT

ALT, AST, GGT,TB, DB, TP, ALB, A/G,

N/A

N/A

TG, TC

N/A

19

Zhu 2015 [33]

Qingdan Jiangzhi decoction

Diet and exercise

Tiopronin enteric-coated tablets

Diet and exercise

12 weeks

Yes

N/A

BU

N/A

N/A

N/A

N/A

N/A

20

Li 2015 [64]

Huatan Lishi Huoxue granule combined granule decoction

Diet and exercise

Polyene phosphatidylcholine capsules

Diet and exercise

3 months

Yes

Yes

CT

ALT

N/A

N/A

TG

N/A

21

Chen et al., 2015 [101]

Zaozhu Yinchen decoction

N/A

Silymarin meglumine tablet

N/A

2 months

Yes

Yes

BU

ALT, AST

N/A

N/A

TG, TC

N/A

22

Yu et al., 2015 [52]

Tiaogan Lipi recipe

Diet and exercise

Placebo

Diet and exercise

12 weeks

Yes

Yes

CT

ALT, AST, GGT

N/A

N/A

TG, TC

N/A

23

Li et al., 2015 [58]

Qinghua decoction

Diet and exercise

N/A

Diet and exercise

6 months

Yes

N/A

BU

ALT, AST, GGT, TB

BMI, WHR

N/A

TG, TC

N/A

24

Liu et al., 2014 [49]

Heze lipid-lowering oral liquid

N/A

Polyene phosphatidylcholine capsules

N/A

4 months

Yes

N/A

CT

ALP, AST, GGT, GLP, ALB

BMI

N/A

TG, TC, HDL-C, LDL-C

N/A

25

Liu et al., 2014 [50]

Ruangan Jiangzhi capsule

Diet and exercise

Polyene phosphatidylcholine capsules

Diet and exercise

12 weeks

Yes

Yes

BU

ALT, GGT

N/A

N/A

TG, TC

N/A

26

Li et al., 2014 [51]

Jianpi Shugan recipe

Diet and exercise

Polyene phosphatidylcholine capsules

Diet and exercise

3 months

Yes

Yes

CT

ALT

N/A

N/A

N/A

N/A

27

Zhu et al., 2014 [102]

Zhigan pill

N/A

Placebo

N/A

3 months

Yes

N/A

BU

N/A

N/A

N/A

N/A

N/A

28

Wen et al., 2014 [60]

Jiangan Xiaozhi granule

Diet and exercise

Hedan tablet

Diet and exercise

3 months

Yes

Yes

CT

ALT, AST, GGT

N/A

N/A

TG, TC, HDL-C, LDL-C

N/A

29

Deng, 2013 [103]

Jiangan Sanqing decoction

N/A

Polyene Phosphatidylcholine capsules

N/A

3 months

Yes

N/A

BU

ALT, AST

N/A

N/A

TG, TC

N/A

30

Li et al., 2013 [54]

Jianpi Huatan Zhuyu prescription

N/A

Qianggan capsule

N/A

3 months

Yes

Yes

BU

ALT, AST, GGT

N/A

N/A

TG, TC

N/A

31

Song et al., 2013 [104]

Modified Linggui Zhugan decoction

N/A

Polyene phosphatidylcholine capsules

N/A

3 months

Yes

N/A

CT

ALT, AST

N/A

N/A

TG, TC

N/A

32

Li et al., 2013 [42]

Qushi Huayu decoction

N/A

Polyene phosphatidylcholine capsules

N/A

24 weeks

Yes

Yes

BU

ALT, AST

N/A

N/A

TG, TC, HDL-C, LDL-C

N/A

33

Wong et al., 2013 [26]

Phyllanthus urinaria

Diet and exercise

Placebo

Diet and exercise

24 weeks

N/A

Yes

N/A

ALT, AST

N/A

HbA1

HDL-C, LDL-C

N/A

34

Pan et al., 2013 [27]

Jiang Zhi granule

Diet and exercise

Placebo

Diet and exercise

24 weeks

N/A

Yes

CT

N/A

BMI

N/A

TG, TC

N/A

35

Chen et al., 2012 [45]

Jindanwang mixture

Diet

Ursodeoxycholic acid capsules

Diet

24 weeks

Yes

N/A

BU, CT

ALT, AST

N/A

N/A

TG, TC

N/A

36

Zhao et al., 2012 [30]

Huatan Xiezhuo recipe

Diet and exercise

Polyene phosphatidylcholine capsules

Diet and exercise

3 months

Yes

Yes

N/A

ALT

BMI

N/A

TG

N/A

37

Wang et al., 2012 [65]

Yigan Jiedu decoction

Diet and exercise

Silymarin

Diet and exercise

2 months

Yes

N/A

N/A

ALT, AST, GGT

N/A

N/A

TG, TC

N/A

38

Pei et al., 2012 [70]

Qinggan Huatan Huoxue recipe

Diet and exercise

Danning tablet

Diet and exercise

3 months

Yes

Yes

BU

ALT, AST, GGT

BMI

FBG, FNIs, HOMA-IR

TG, TC, HDL-C, LDL-C

N/A

39

Wu 2012 [83]

Jianpi Huatan formula

N/A

Vitamin E

N/A

3 months

N/A

Yes

BU

ALT, AST

N/A

FBG, FNIs, HOMA-IR

TG, TC, HDL-C, LDL-C

N/A

40

Tong et al., 2011 [105]

Jiedu Jianpi Tongluo decoction

N/A

Silibinin capsules

N/A

12 weeks

Yes

Yes

BU

ALT, AST, GGT, TB

N/A

N/A

TG, TC, HDL-C, LDL-C

N/A

41

Zhang et al., 2011 [66]

Kangzhi decoction

N/A

Tiopronin enteric-coated tablets

N/A

6 months

Yes

Yes

BU, CT

ALT, AST, GGT

N/A

N/A

TG, TC

N/A

42

Gu et al., 2011 [61]

Zhigan capsule

Diet and exercise

Polyene phosphatidylcholine capsules

Diet and exercise

3 months

Yes

Yes

BU

ALT, AST, GGT

BMI

FBG

TG, TC, LDL-C

N/A

43

Zhao et al., 2010 [46]

Qiyin tea

N/A

Polyene phosphatidylcholine capsules

N/A

2 months

Yes

N/A

BU

AST, ALP, AST, GGT

N/A

N/A

TG, TC

N/A

44

Ding et al., 2010 [88]

Pingganjian decoction

Diet and exercise

Silymarin, Ultivarietas Oryzae Saltlicae Et Monasci

Diet and exercise

3 months

Yes

Yes

CT

ALT, AST

BMI,WHR

FBG, FNIs, HOMA-IR

TG, TC

N/A

45

Pan et al., 2010 [32]

Tiaozhiji granules

N/A

Hedan tablet

N/A

3 months

Yes

Yes

BU, CT

ALT, AST, GGT

N/A

N/A

TG, TC

N/A

46

Liu et al., 2008 [67]

Qiyin granules

Diet and exercise

Polyene phosphatidylcholine capsules

Diet and exercise

2 months

Yes

N/A

BU

ALT, AST

N/A

N/A

TG, TC

N/A

47

Ji et al., 2008 [25]

Danning tablet

Diet and exercise

Ursodeoxycholic acid tablet

Diet and exercise

24 weeks

Yes

Yes

CT

ALT, AST, GGT

BMI

N/A

TG, TC

N/A

48

Chen et al., 2008 [29]

Xiaoyao San decoction and Danggui Shaoyao San decoction

Diet

Anethol trithione

Diet

3 months

Yes

N/A

BU

ALT, AST

N/A

N/A

TG, TC

N/A

49

Lou et al., 2008 [44]

Yiqi Sanju formula

N/A

Placebo

N/A

3 months

Yes

Yes

CT

ALT, AST

BMI

FBG, FNIs, HOMA-IR

TG, TC, HDL-C, LDL-C

hs-CRP, TNF-α

50

Li et al., 2007 [55]

Jianpi Bushen decoction

N/A

Silibinin

N/A

8 weeks

Yes

Yes

BU

ALT, AST, GGT,TB

N/A

N/A

TG, TC, HDL-C, LDL-C

N/A

51

Yang et al., 2007 [56]

Yigan Jiangzhi capsule

N/A

Dongbao Gantai tablet

N/A

3 months

N/A

N/A

BU, CT

ALT, AST, GGT

N/A

N/A

TG, TC, HDL-C, LDL-C

N/A

52

Gu et al., 2007 [24]

Tiaozhi Yanggan decoction

Diet and exercise

Thiola tablet

Diet and exercise

12 weeks

Yes

Yes

N/A

ALT, AST, GGT

N/A

N/A

TG, TC, HDL-C, LDL-C

N/A

53

Chen et al., 2006 [57]

Qianggan capsule

Diet and exercise

Tiopronin

Diet and exercise

3 months

N/A

N/A

BU

ALT, GGT

N/A

N/A

TG

N/A

No.

Authors, year

Overall findings

Efficacy

Safety

Overall efficacy rate of test group

Overall efficacy rate of control group

Difference between the 2 groups

Non-serious

Serious

1

Wu et al., 2020 [43]

93.33%

80.00%

Test group (P < 0.05)

N/A

N/A

2

Lyv et al., 2020 [47]

100.00%

48.39%

Test group (P < 0.05)

N/A

N/A

3

Yang et al., 2019 [59]

86.67%

73.33%

Test group (P < 0.01)

N/A

N/A

4

Yang et al., 2019 [97]

64.00%

52.00%

Test group (P < 0.05)

N/A

N/A

5

Li et al., 2018 [62]

84.13%

56.45%

Test group (P < 0.01)

None

None

6

Chen et al., 2017 [98]

89.7%

84.0%

Test group (P < 0.05)

N/A

N/A

7

Hu et al., 2017 [31]

94.28%

77.14%

Test group (P < 0.01)

None

None

8

Jiang et al., 2017 [41]

Specific outcome readings

Specific outcome readings

Test group (P < 0.01)

ADR1

None

9

Yang et al., 2017 [53]

93.02%

68.18%

Test group (P < 0.01)

N/A

N/A

10

Jeong et al., 2017 [28]

Specific outcome readings

Specific outcome readings

High dose group (P = 0.033)

ADR2

None

Specific outcome readings

Specific outcome readings

Low dose group (P = 0.386)

11

Sun et al., 2017 [68]

93.33%

61.67%

Test group (P < 0.01)

N/A

N/A

12

Niu 2016 [48]

95.00%

76.60%

Test group (P < 0.05)

N/A

N/A

13

Zhang et al., 2016 [99]

92.31%

78.85%

Test group (P < 0.05)

None

None

14

Zhang et al., 2016 [34]

33.80%

23.39%

Test group (P < 0.05)

N/A

N/A

15

Qi et al., 2016 [63]

93.30%

62.20%

Test group (P < 0.05)

N/A

N/A

16

Tan et al., 2016 [100]

87.23%

71.11%

Test group (P < 0.05)

ADR3

None

17

Yu et al., 2016 [69]

Specific outcome readings

Specific outcome readings

Test group (P < 0.01)

N/A

N/A

18

Yin et al., 2016 [35]

81.63%

62.5%

Test group (P < 0.05)

N/A

N/A

19

Zhu, 2015 [33]

Specific outcome readings

Specific outcome readings

Test group (P < 0.05)

N/A

N/A

20

Li, 2015 [64]

98.10%

80.80%

Test group (P < 0.05)

None

None

21

Chen et al., 2015 [101]

87.50%

73.68%

Test group (P < 0.05)

None

None

22

Yu et al., 2015[52]

Specific outcome readings

Specific outcome readings

Test group (P < 0.05)

None

None

23

Li et al., 2015 [58]

58.33%

30.51%

Test group (P < 0.01)

N/A

N/A

24

Liu et al., 2014 [49]

52.94%

29.09%

Test group (P < 0.05)

N/A

N/A

25

Liu et al., 2014 [50]

91.67%

56.67%

Test group (P < 0.05)

ADR4

None

26

Li et al., 2014 [51]

84.09%

75.00%

Test group (P < 0.05)

ADR5

None

27

Zhu et al., 2014 [102]

85.83%

63.16%

Test group (P < 0.05)

N/A

N/A

28

Wen et al., 2014 [60]

78.40%

55.60%

Test group (P < 0.05)

None

None

29

Deng, 2013 [103]

90.00%

70.00%

Test group (P < 0.05)

N/A

N/A

30

Li et al., 2013 [54]

86.60%

66.60%

Test group (P < 0.05)

None

None

31

Song et al., 2013 [104]

91.70%

69.00%

Test group (P < 0.01)

N/A

N/A

32

Li et al., 2013 [42]

specific outcome readings

specific outcome readings

Test group (P < 0.01)

ADR6

None

33

Wong et al., 2013 [26]

Specific outcome readings

Specific outcome readings

Not siginificant

ADR7

ADR8

34

Pan et al., 2013 [27]

Specific outcome readings

Specific outcome readings

Test group (P < 0.05)

ADR9

None

35

Chen et al., 2012 [45]

94.00%

92.00%

No siginificant differences (P > 0.05)

N/A

N/A

36

Zhao et al., 2012 [30]

Specific outcome readings

Specific outcome readings

Test group (P < 0.01)

None

None

37

Wang et al., 2012 [65]

75.56%

51.11%

Test group (P < 0.01)

N/A

N/A

38

Pei et al., 2012 [70]

87.20%

73.60%

Test group (P < 0.05)

ADR10

None

39

Wu 2012 [83]

83.30%

46.67%

Test group (P < 0.05)

None

None

40

Tong et al., 2011 [105]

86.67%

76.09%

Test group (P < 0.05)

None

None

41

Zhang et al., 2011 [66]

86.90%

67.70%

Test group (P < 0.05)

None

None

42

Gu et al., 2011 [61]

90.00%

72.00%

Test group (P < 0.05)

ADR11

None

43

Zhao et al., 2010 [46]

87.60%

83.90%

No siginificant differences (p = 0.873)

N/A

N/A

44

Ding et al., 2010 [88]

83.33%

45.10%

Test group (P < 0.05)

ADR12

None

45

Pan et al., 2010 [32]

Specific outcome readings

Specific outcome readings

Test group (P < 0.05)

None

None

46

Liu et al., 2008 [67]

Specific outcome readings

Specific outcome readings

Test group (P < 0.05)

N/A

N/A

47

Ji et al., 2008 [25]

Specific outcome readings

Specific outcome readings

Test group (P < 0.05)

ADR13

None

48

Chen et al., 2008 [29]

96.77%

83.87%

Test group (P < 0.05)

N/A

N/A

49

Lou et al., 2008 [44]

94.87%

32.14%

Test group (P < 0.01)

ADR14

None

50

Li et al., 2007 [55]

87.23%

71.11%

Test group (P < 0.05)

None

None

51

Yang et al., 2007 [56]

88.20%

71.70%

Test group (P < 0.05)

N/A

N/A

52

Gu et al., 2007 [24]

81.19%

68.97%

Test group (P < 0.05)

ADR15

None

53

Chen et al., 2006 [57]

79.69%

62.07%

Test group (P < 0.05)

N/A

N/A

  1. ALB albumin, ALP alkaline phosphatases, ALT aminotransferase, AST aspartate aminotransferase, A/G albumin/globulin ratio, BU B-ultrasound, CT computed tomography, DAO diamine oxidase, DB direct bilirubin, FBG fasting blood glucose, FINS fasting plasma insulin, GGT gamma-glutamyl-transpeptidase, GLB globulin, HDL high density lipoprotein-cholesterol, HFC hepatic fat content, HOMA-IR homeostasis model assessment-estimated insulin resistance, hs-CRP high sensitivity C-reactive protein, L/S ratio liver to spleen ratio, LDL low density lipoprotein-cholesterol, MRS magnetic resonance spectroscopy, TB total bilirubin, TC total cholesterol, TG triglyceride, TP total serum protein, TNF-α tumor necrosis factor-α, VLDL very low density lipoprotein, WHR waist/hip ratio
  2. ADR1: one patient in the control group had a mild prothrombin time
  3. ADR2: high dose group: abdominal pain upper(1 patient); low dose group: dizziness(1 patient); Palcebo group: nausea (1 patient)
  4. ADR3: one case in the control group had mild edema of both lower limbs
  5. ADR4: 4 patients in the test group had different degrees of diarrhea
  6. ADR5: 1 case in test group; 3 cases in control group(not specified)
  7. ADR6: in the test group, 3 cases developed nausea and 2 cases of gastric cavity discomfort; in the control group, 2 cases of gastric cavity discomfort
  8. ADR7: dyspepsia, diarrhea, per-rectal bleeding, chest pain, cough, headache, blurred vision, toothache, gum bleeding, flu-like symptoms
  9. ADR8: hospitalization occurred in two patients in the Phyllanthus group (back pain, stroke) and one patient in the placebo group (acute appendicitis)
  10. ADR9: 16 patients with 19 cases of adverse events were reported in the test group, and 14 patients with 19 cases were reported tn the control group (no mention of the mild adverse name). 1 case exhaustion/dizziness and 1 case sloppy stool were related the study
  11. ADR10: 3 cases in the test group had loose stools; In the control group, 2 cases had nausea and 5 cases had loose stools
  12. ADR11: 5 patients in the test group had different degrees of diarrhea symptoms
  13. ADR12: in the test group, 3 patients had mild diarrhea, gastrointestinal discomfort and reduced appetite, 1 case of hypertension; In the control group 2 cases of hypertension
  14. ADR13: in test group, most of pat ients showed diarrhea. There was one patient with skin rash and three patients with nausea
  15. ADR14: in the test group, 3 patients developed mild diarrhea, recovered and decreased appetite
  16. ADR15: 21 cases of diarrhea, 22 of gastric discomfort or light pain, 15 of abdominal discomfort or dull pain, and 11 cases of nausea